fifteen patients with mild-to-moderate hypertension ( 10 with normal and five with decreased renal function ) were studied after treatment with placebo and low ( 1 mg ) , intermediate ( 2.5 mg ) , and high ( 5.0 mg per day ) doses of indapamide , each for four weeks .
C0020538
hypertension
C0021186
indapamide